Avantor’s (AVTR) Neutral Rating Reiterated at UBS Group

Avantor (NYSE:AVTR)‘s stock had its “neutral” rating reaffirmed by analysts at UBS Group in a research note issued on Friday,Benzinga reports. They currently have a $25.00 target price on the stock, down from their prior target price of $29.00. UBS Group’s target price suggests a potential upside of 10.60% from the stock’s previous close.

A number of other brokerages have also commented on AVTR. Barclays cut their target price on Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research note on Friday, October 25th. Robert W. Baird dropped their price objective on shares of Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday, October 28th. Wells Fargo & Company decreased their target price on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research report on Monday, October 28th. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $34.00 price target on shares of Avantor in a research report on Thursday, September 26th. Three investment analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. According to data from MarketBeat, Avantor presently has an average rating of “Moderate Buy” and a consensus price target of $27.38.

Avantor Trading Up 3.9 %

Avantor stock opened at $22.60 on Friday. The business has a 50 day moving average price of $21.47 and a two-hundred day moving average price of $23.35. The company has a quick ratio of 1.06, a current ratio of 1.54 and a debt-to-equity ratio of 0.84. Avantor has a 12 month low of $19.59 and a 12 month high of $28.00. The stock has a market cap of $15.38 billion, a price-to-earnings ratio of 49.14, a price-to-earnings-growth ratio of 3.42 and a beta of 1.28.

Hedge Funds Weigh In On Avantor

A number of institutional investors and hedge funds have recently bought and sold shares of AVTR. Canada Pension Plan Investment Board raised its holdings in shares of Avantor by 6.8% in the second quarter. Canada Pension Plan Investment Board now owns 22,927,325 shares of the company’s stock valued at $486,059,000 after buying an additional 1,463,695 shares during the last quarter. State Street Corp increased its position in Avantor by 58.0% in the 3rd quarter. State Street Corp now owns 22,368,244 shares of the company’s stock valued at $578,666,000 after acquiring an additional 8,206,695 shares in the last quarter. Janus Henderson Group PLC raised its stake in shares of Avantor by 18.2% in the third quarter. Janus Henderson Group PLC now owns 17,692,705 shares of the company’s stock worth $457,710,000 after acquiring an additional 2,719,615 shares during the last quarter. Geode Capital Management LLC lifted its position in shares of Avantor by 7.1% during the third quarter. Geode Capital Management LLC now owns 11,150,788 shares of the company’s stock worth $287,791,000 after purchasing an additional 739,667 shares in the last quarter. Finally, 1832 Asset Management L.P. grew its stake in shares of Avantor by 1,634.9% during the second quarter. 1832 Asset Management L.P. now owns 8,530,118 shares of the company’s stock valued at $180,839,000 after purchasing an additional 8,038,451 shares during the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.